AAAAAA

   
Results: 1-19 |
Results: 19
RANDOMIZED, CONTROLLED-STUDY OF THE SAFETY AND EFFICACY OF INTRAVENOUS CIDOFOVIR FOR THE TREATMENT OF RELAPSING CYTOMEGALOVIRUS RETINITIS IN PATIENTS WITH AIDS
Authors: LALEZARI JP HOLLAND GN KRAMER F MCKINLEY GF KEMPER CA IVES DV NELSON R HARDY WD KUPPERMANN BD NORTHFELT DW YOULE M JOHNSON M LEWIS RA WEINBERG DV SIMON GL WOLITZ RA RUBY AE STAGG RJ JAFFE HS
Citation: Jp. Lalezari et al., RANDOMIZED, CONTROLLED-STUDY OF THE SAFETY AND EFFICACY OF INTRAVENOUS CIDOFOVIR FOR THE TREATMENT OF RELAPSING CYTOMEGALOVIRUS RETINITIS IN PATIENTS WITH AIDS, Journal of acquired immune deficiency syndromes and human retrovirology, 17(4), 1998, pp. 339-344
LOSS OF SERUM HBV DNA AND HBEAG AND SEROCONVERSION FOLLOWING SHORT-TERM (12 WEEKS) ADEFOVIR DIPIVOXIL THERAPY IN CHRONIC HEPATITIS-B - 2 PLACEBO-CONTROLLED PHASE-II STUDIES
Authors: HEATHCOTE EJ JEFFERS L WRIGHT T SHERMAN M PERRILLO R SACKS S CARITHERS R RUSTGI V DIBISCEGLIE A VALAN V MURRAY A ROONEY J JAFFE HS
Citation: Ej. Heathcote et al., LOSS OF SERUM HBV DNA AND HBEAG AND SEROCONVERSION FOLLOWING SHORT-TERM (12 WEEKS) ADEFOVIR DIPIVOXIL THERAPY IN CHRONIC HEPATITIS-B - 2 PLACEBO-CONTROLLED PHASE-II STUDIES, Hepatology, 28(4), 1998, pp. 620-620
EXTENDED TREATMENT WITH ADEFOVIR DIPIVOXIL IN PATIENTS WITH CHRONIC HEPATITIS-B VIRUS-INFECTION
Authors: GILSON RJC MURRAYLYON IM NELSON MR RICE SJ TEDDER RS MURRAY A JAFFE HS WELLER IVD
Citation: Rjc. Gilson et al., EXTENDED TREATMENT WITH ADEFOVIR DIPIVOXIL IN PATIENTS WITH CHRONIC HEPATITIS-B VIRUS-INFECTION, Hepatology, 28(4), 1998, pp. 1316-1316
A MULTICENTER PHASE I II DOSE-ESCALATION STUDY OF SINGLE-DOSE CIDOFOVIR GEL FOR TREATMENT OF RECURRENT GENITAL HERPES/
Authors: SACKS SL SHAFRAN SD DIAZMITOMA F TROTTIER S SIBBALD RG HUGHES A SAFRIN S RUDY J MCGUIRE B JAFFE HS
Citation: Sl. Sacks et al., A MULTICENTER PHASE I II DOSE-ESCALATION STUDY OF SINGLE-DOSE CIDOFOVIR GEL FOR TREATMENT OF RECURRENT GENITAL HERPES/, Antimicrobial agents and chemotherapy, 42(11), 1998, pp. 2996-2999
CLINICAL USES OF CIDOFOVIR
Authors: SAFRIN S CHERRINGTON J JAFFE HS
Citation: S. Safrin et al., CLINICAL USES OF CIDOFOVIR, Reviews in medical virology, 7(3), 1997, pp. 145-156
THE SAFETY AND EFFICACY OF ADEFOVIR DIPIVOXIL, A NOVEL ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) THERAPY, IN HIV-INFECTED ADULTS - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
Authors: DEEKS SG COLLIER A LALEZARI J PAVIA A RODRIGUE D DREW WL TOOLE J JAFFE HS MULATO AS LAMY PD LI WX CHERRINGTON JM HELLMANN N KAHN J
Citation: Sg. Deeks et al., THE SAFETY AND EFFICACY OF ADEFOVIR DIPIVOXIL, A NOVEL ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) THERAPY, IN HIV-INFECTED ADULTS - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL, The Journal of infectious diseases, 176(6), 1997, pp. 1517-1523
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF CIDOFOVIR GELFOR THE TREATMENT OF ACYCLOVIR-UNRESPONSIVE MUCOCUTANEOUS HERPES-SIMPLEX VIRUS-INFECTION IN PATIENTS WITH AIDS
Authors: LALEZARI J SCHACKER T FEINBERG J GATHE J LEE S CHEUNG T KRAMER F KESSLER H COREY L DREW WL BOGGS J MCGUIRE B JAFFE HS SAFRIN S
Citation: J. Lalezari et al., A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF CIDOFOVIR GELFOR THE TREATMENT OF ACYCLOVIR-UNRESPONSIVE MUCOCUTANEOUS HERPES-SIMPLEX VIRUS-INFECTION IN PATIENTS WITH AIDS, The Journal of infectious diseases, 176(4), 1997, pp. 892-898
ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) ACTIVITY, SAFETY, AND PHARMACOKINETICS OF ADEFOVIR DIPIVOXIL PIVALOYLOXYMETHYL)-PHOSPHONYLMETHOXYETHYL]ADENINE) IN HIV-INFECTED PATIENTS
Authors: BARDITCHCROVO P TOOLE J HENDRIX CW CUNDY KC EBELING D JAFFE HS LIETMAN PS
Citation: P. Barditchcrovo et al., ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) ACTIVITY, SAFETY, AND PHARMACOKINETICS OF ADEFOVIR DIPIVOXIL PIVALOYLOXYMETHYL)-PHOSPHONYLMETHOXYETHYL]ADENINE) IN HIV-INFECTED PATIENTS, The Journal of infectious diseases, 176(2), 1997, pp. 406-413
INTRAVENOUS CIDOFOVIR FOR PERIPHERAL CYTOMEGALOVIRUS RETINITIS IN PATIENTS WITH AIDS - A RANDOMIZED, CONTROLLED TRIAL
Authors: LALEZARI JP STAGG RJ KUPPERMANN BD HOLLAND GN KRAMER F IVES DV YOULE M ROBINSON MR DREW WL JAFFE HS
Citation: Jp. Lalezari et al., INTRAVENOUS CIDOFOVIR FOR PERIPHERAL CYTOMEGALOVIRUS RETINITIS IN PATIENTS WITH AIDS - A RANDOMIZED, CONTROLLED TRIAL, Annals of internal medicine, 126(4), 1997, pp. 257
CIDOFOVIR, A NEW AGENT WITH POTENT ANTI-HERPESVIRUS ACTIVITY
Authors: HITCHCOCK MJM JAFFE HS MARTIN JC STAGG RJ
Citation: Mjm. Hitchcock et al., CIDOFOVIR, A NEW AGENT WITH POTENT ANTI-HERPESVIRUS ACTIVITY, Antiviral chemistry & chemotherapy, 7(3), 1996, pp. 115-127
PLACEBO-CONTROLLED PHASE I II STUDY OF ADEFOVIR DIPIVOXIL (BIS-POM PMEA) IN PATIENTS WITH CHRONIC HEPATITIS-B INFECTION/
Authors: GILSON RJC CHOPRA K MURRAYLYON I NEWELL A NELSON M TEDDER RS TOOLE J JAFFE HS HELLMANN N WELLER IVD
Citation: Rjc. Gilson et al., PLACEBO-CONTROLLED PHASE I II STUDY OF ADEFOVIR DIPIVOXIL (BIS-POM PMEA) IN PATIENTS WITH CHRONIC HEPATITIS-B INFECTION/, Hepatology, 24(4), 1996, pp. 620-620
PHARMACOKINETICS, SAFETY AND BIOAVAILABILITY OF HPMPC (CIDOFOVIR) IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED SUBJECTS
Authors: WACHSMAN M PETTY BG CUNDY KC JAFFE HS FISHER PE PASTELAK A LIETMAN PS
Citation: M. Wachsman et al., PHARMACOKINETICS, SAFETY AND BIOAVAILABILITY OF HPMPC (CIDOFOVIR) IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED SUBJECTS, Antiviral research, 29(2-3), 1996, pp. 153-161
CLINICAL PHARMACOKINETICS OF CIDOFOVIR IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS
Authors: CUNDY KC PETTY BG FLAHERTY J FISHER PE POLIS MA WACHSMAN M LIETMAN PS LALEZARI JP HITCHCOCK MJM JAFFE HS
Citation: Kc. Cundy et al., CLINICAL PHARMACOKINETICS OF CIDOFOVIR IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS, Antimicrobial agents and chemotherapy, 39(6), 1995, pp. 1247-1252
ANTICYTOMEGALOVIRAL ACTIVITY AND SAFETY OF CIDOFOVIR IN PATIENTS WITHHUMAN-IMMUNODEFICIENCY-VIRUS INFECTION AND CYTOMEGALOVIRUS VIRURIA
Authors: POLIS MA SPOONER KM BAIRD BF MANISCHEWITZ JF JAFFE HS FISHER PE FALLOON J DAVEY RT KOVACS JA WALKER RE WHITCUP SM NUSSENBLATT RB LANE HC MASUR H
Citation: Ma. Polis et al., ANTICYTOMEGALOVIRAL ACTIVITY AND SAFETY OF CIDOFOVIR IN PATIENTS WITHHUMAN-IMMUNODEFICIENCY-VIRUS INFECTION AND CYTOMEGALOVIRUS VIRURIA, Antimicrobial agents and chemotherapy, 39(4), 1995, pp. 882-886
CLINICAL PHARMACOKINETICS OF ADEFOVIR IN HUMAN-IMMUNODEFICIENCY-VIRUSTYPE 1-INFECTED PATIENTS
Authors: CUNDY KC BARDITCHCROVO P WALKER RE COLLIER AC EBELING D TOOLE J JAFFE HS
Citation: Kc. Cundy et al., CLINICAL PHARMACOKINETICS OF ADEFOVIR IN HUMAN-IMMUNODEFICIENCY-VIRUSTYPE 1-INFECTED PATIENTS, Antimicrobial agents and chemotherapy, 39(11), 1995, pp. 2401-2405
-1-[3-HYDROXY-2-(PHOSPHONYLMETHOXY)PROPYL]CYTOSINE (CIDOFOVIR) - RESULTS OF A PHASE I II STUDY OF A NOVEL ANTIVIRAL NUCLEOTIDE ANALOG/
Authors: LALEZARI JP DREW WL GLUTZER E JAMES C MINER D FLAHERTY J FISHER PE CUNDY K HANNIGAN J MARTIN JC JAFFE HS
Citation: Jp. Lalezari et al., -1-[3-HYDROXY-2-(PHOSPHONYLMETHOXY)PROPYL]CYTOSINE (CIDOFOVIR) - RESULTS OF A PHASE I II STUDY OF A NOVEL ANTIVIRAL NUCLEOTIDE ANALOG/, The Journal of infectious diseases, 171(4), 1995, pp. 788-796
TREATMENT WITH INTRAVENOUS -1-[3-HYDROXY-2-(PHOSPHONYLMETHOXY)PROPYL]CYTOSINE OF ACYCLOVIR-RESISTANT MUCOCUTANEOUS INFECTION WITH HERPES-SIMPLEX VIRUS IN A PATIENT WITH AIDS
Authors: LALEZARI JP DREW WL GLUTZER E MINER D SAFRIN S OWEN WF DAVIDSON JM FISHER PE JAFFE HS
Citation: Jp. Lalezari et al., TREATMENT WITH INTRAVENOUS -1-[3-HYDROXY-2-(PHOSPHONYLMETHOXY)PROPYL]CYTOSINE OF ACYCLOVIR-RESISTANT MUCOCUTANEOUS INFECTION WITH HERPES-SIMPLEX VIRUS IN A PATIENT WITH AIDS, The Journal of infectious diseases, 170(3), 1994, pp. 570-572
EFFECT OF INTERFERON-GAMMA ON INFECTION-RELATED DEATH IN PATIENTS WITH SEVERE INJURIES - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
Authors: DRIES DJ JURKOVICH GJ MAIER RV CLEMMER TP STRUVE SN WEIGELT JA STANFORD GG HERR DL CHAMPION HR LEWIS FR HOYT D HANSBROUGH J YELLIN AE BERNE TV TRUNKEY D JAFFE HS MUNERA C FISHER P STARKO KM
Citation: Dj. Dries et al., EFFECT OF INTERFERON-GAMMA ON INFECTION-RELATED DEATH IN PATIENTS WITH SEVERE INJURIES - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL, Archives of surgery, 129(10), 1994, pp. 1031-1041
TREATMENT OF STEROID-DEPENDENT ASTHMA WITH RECOMBINANT INTERFERON-GAMMA
Authors: BOGUNIEWICZ M SCHNEIDER LC MILGROM H NEWELL D KELLY N TAM P IZU AE JAFFE HS BUCALO LR LEUNG DYM
Citation: M. Boguniewicz et al., TREATMENT OF STEROID-DEPENDENT ASTHMA WITH RECOMBINANT INTERFERON-GAMMA, Clinical and experimental allergy, 23(9), 1993, pp. 785-790
Risultati: 1-19 |